0000899243-16-017730.txt : 20160406 0000899243-16-017730.hdr.sgml : 20160406 20160406174419 ACCESSION NUMBER: 0000899243-16-017730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160404 FILED AS OF DATE: 20160406 DATE AS OF CHANGE: 20160406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shaff Eric D. CENTRAL INDEX KEY: 0001643734 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 161558427 MAIL ADDRESS: STREET 1: C/O SERES HEALTH, INC. STREET 2: 161 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-04-04 0 0001609809 Seres Therapeutics, Inc. MCRB 0001643734 Shaff Eric D. C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 0 1 0 0 CFO and EVP Common Stock 2016-04-04 4 M 0 6568 7.79 A 6568 D Common Stock 2016-04-04 4 S 0 6568 28.85 D 0 D Stock Option (right to buy) 7.79 2016-04-04 4 M 0 6568 0.00 D 2024-12-08 Common Stock 6568 242988 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted on February 26, 2016 by the Reporting Person. The option vested as to 25% of the shares subject to the option on November 17, 2015, and has vested or will vest as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter. /s/ Eric D. Shaff 2016-04-06